DexCom Cost of Goods Sold 2010-2025 | DXCM
DexCom annual/quarterly cost of goods sold history and growth rate from 2010 to 2025. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- DexCom cost of goods sold for the quarter ending March 31, 2025 was $447M, a 24.48% increase year-over-year.
- DexCom cost of goods sold for the twelve months ending March 31, 2025 was $1.683B, a 19.04% increase year-over-year.
- DexCom annual cost of goods sold for 2024 was $1.595B, a 19.6% increase from 2023.
- DexCom annual cost of goods sold for 2023 was $1.333B, a 29.87% increase from 2022.
- DexCom annual cost of goods sold for 2022 was $1.027B, a 33.68% increase from 2021.
| DexCom Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024 | $1,595 |
| 2023 | $1,333 |
| 2022 | $1,027 |
| 2021 | $768 |
| 2020 | $647 |
| 2019 | $545 |
| 2018 | $368 |
| 2017 | $226 |
| 2016 | $195 |
| 2015 | $124 |
| 2014 | $83 |
| 2013 | $60 |
| 2012 | $53 |
| 2011 | $40 |
| 2010 | $30 |
| 2009 | $26 |
| DexCom Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2025-03-31 | $447 |
| 2024-12-31 | $458 |
| 2024-09-30 | $400 |
| 2024-06-30 | $378 |
| 2024-03-31 | $359 |
| 2023-12-31 | $378 |
| 2023-09-30 | $352 |
| 2023-06-30 | $325 |
| 2023-03-31 | $279 |
| 2022-12-31 | $274 |
| 2022-09-30 | $275 |
| 2022-06-30 | $247 |
| 2022-03-31 | $231 |
| 2021-12-31 | $226 |
| 2021-09-30 | $203 |
| 2021-06-30 | $178 |
| 2021-03-31 | $161 |
| 2020-12-31 | $170 |
| 2020-09-30 | $161 |
| 2020-06-30 | $168 |
| 2020-03-31 | $149 |
| 2019-12-31 | $154 |
| 2019-09-30 | $149 |
| 2019-06-30 | $130 |
| 2019-03-31 | $112 |
| 2018-12-31 | $115 |
| 2018-09-30 | $98 |
| 2018-06-30 | $89 |
| 2018-03-31 | $66 |
| 2017-12-31 | $68 |
| 2017-09-30 | $58 |
| 2017-06-30 | $53 |
| 2017-03-31 | $48 |
| 2016-12-31 | $55 |
| 2016-09-30 | $48 |
| 2016-06-30 | $52 |
| 2016-03-31 | $41 |
| 2015-12-31 | $40 |
| 2015-09-30 | $31 |
| 2015-06-30 | $27 |
| 2015-03-31 | $26 |
| 2014-12-31 | $25 |
| 2014-09-30 | $22 |
| 2014-06-30 | $19 |
| 2014-03-31 | $17 |
| 2013-12-31 | $18 |
| 2013-09-30 | $15 |
| 2013-06-30 | $14 |
| 2013-03-31 | $13 |
| 2012-12-31 | $16 |
| 2012-09-30 | $15 |
| 2012-06-30 | $12 |
| 2012-03-31 | $11 |
| 2011-12-31 | $12 |
| 2011-09-30 | $10 |
| 2011-06-30 | $10 |
| 2011-03-31 | $9 |
| 2010-12-31 | $9 |
| 2010-09-30 | $8 |
| 2010-06-30 | $7 |
| 2010-03-31 | $6 |
| 2009-12-31 | $6 |
| 2009-09-30 | $6 |
| 2009-06-30 | $8 |
| 2009-03-31 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $31.306B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $184.618B | 80.86 |
| Thermo Fisher Scientific (TMO) | United States | $151.077B | 18.27 |
| Edwards Lifesciences (EW) | United States | $44.183B | 28.97 |
| IDEXX Laboratories (IDXX) | United States | $42.193B | 48.49 |
| Alcon (ALC) | Switzerland | $42.098B | 28.45 |
| IQVIA Holdings (IQV) | United States | $26.844B | 15.04 |
| Mettler-Toledo (MTD) | United States | $24.183B | 28.76 |
| STERIS (STE) | Ireland | $23.305B | 25.67 |
| Waters (WAT) | United States | $20.402B | 28.78 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.717B | 0.00 |
| Hologic (HOLX) | United States | $14.358B | 15.60 |
| Sysmex ADR (SSMXY) | Japan | $10.777B | 30.57 |
| Penumbra (PEN) | United States | $9.854B | 77.34 |
| Masimo (MASI) | United States | $9.115B | 33.62 |
| Globus Medical (GMED) | United States | $7.826B | 18.65 |
| Glaukos (GKOS) | United States | $5.531B | 0.00 |
| Teleflex (TFX) | United States | $5.217B | 8.61 |
| TransMedics (TMDX) | United States | $4.314B | 93.77 |
| Integer Holdings (ITGR) | United States | $4.155B | 21.77 |
| PROCEPT BioRobotics (PRCT) | United States | $3.250B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.485B | 14.80 |
| Nihon Kohden (NHNKY) | Japan | $2.265B | 25.98 |
| Veracyte (VCYT) | United States | $2.092B | 29.35 |
| Elekta AB (EKTAY) | Sweden | $1.872B | 16.83 |
| Alphatec Holdings (ATEC) | United States | $1.587B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.317B | 123.40 |
| Pulse Biosciences (PLSE) | United States | $1.042B | 0.00 |
| OPKO Health (OPK) | United States | $1.007B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.903B | 4.80 |
| IRadimed (IRMD) | United States | $0.756B | 38.38 |
| SiBone (SIBN) | United States | $0.704B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.685B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.560B | 8.71 |
| RxSight (RXST) | United States | $0.550B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.534B | 12.52 |
| OrthoPediatrics (KIDS) | United States | $0.500B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.468B | 12.46 |
| Delcath Systems (DCTH) | United States | $0.462B | 0.00 |
| AxoGen (AXGN) | United States | $0.446B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.406B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.361B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.357B | 0.00 |
| NeuroPace (NPCE) | United States | $0.347B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.318B | 0.00 |
| 908 Devices (MASS) | United States | $0.238B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.236B | 14.32 |
| Neuronetics (STIM) | United States | $0.226B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.224B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.210B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.203B | 0.00 |
| Inogen (INGN) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| CVRx (CVRX) | United States | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.139B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.129B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.101B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.086B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.076B | 46.00 |
| EnVVeno Medical (NVNO) | United States | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.052B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.038B | 0.00 | |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.51 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |